Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges
Author:
Publisher
Elsevier BV
Reference109 articles.
1. Advances in the treatment of multiple sclerosis;Goldschmidt;Neurol Clin,2021
2. Multiple sclerosis progression: time for a new mechanism-driven framework;Kuhlmann;Lancet Neurol,2023
3. Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis;Yong;Nat Rev Neurol,2022
4. Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives;Ontaneda;Lancet Neurol,2015
5. Ocrelizumab versus placebo in primary progressive multiple sclerosis;Montalban;N Engl J Med,2017
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review;Journal of Neurology;2024-09-12
2. Selecting informative patients for phase 2 progressive trials in MS: Design considerations for phase 2 clinical trials in progressive MS;Multiple Sclerosis Journal;2024-09-08
3. Brain atrophy assessment in multiple sclerosis: technical– and subject-related barriers for translation to real-world application in individual subjects;Expert Review of Neurotherapeutics;2024-09-04
4. New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis;Frontiers in Cellular Neuroscience;2024-08-05
5. Investigating cortical hypoxia in multiple sclerosis via time‐domain near‐infrared spectroscopy;Annals of Clinical and Translational Neurology;2024-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3